Who Is Charlotte Figi? Age, Biography and Wiki
Charlotte Figi was born on October 18, 2006, in the United States. She gained worldwide recognition as one of the first patients to receive treatment with cannabidiol (CBD) oil, specifically for her severe epilepsy. Charlotte's battle with Dravet syndrome, a rare form of epilepsy, garnered significant media attention and helped pave the way for the acceptance of medical cannabis in various states across the U.S. Tragically, Charlotte passed away in April 2020, but her legacy continues to live on, inspiring many advocates for medical cannabis.
| Occupation | Other |
|---|---|
| Date of Birth | October 18, 2006 |
| Age | 13 Years |
| Birth Place | N/A |
| Horoscope | Libra |
| Country | U.S |
| Date of death | 7 April, 2020 |
| Died Place | Colorado Springs, Colorado, U.S. |
Popularity
Charlotte Figi's Popularity over time
Height, Weight & Measurements
Charlotte was a young girl, but specific details about her height and weight during her life are not extensively documented. However, as she was only 13 years old at the time of her passing, she was still in her developmental years. Unfortunately, exact measurements won’t be available as she was still growing.
Family, Dating & Relationship Status
As Charlotte was only 13 at her time of passing, there were no public details regarding a boyfriend or girlfriend. She was surrounded by her loving family, who advocated tirelessly for her treatment and the legalization of medical cannabis. Charlotte’s parents played a critical role in her life and legacy, ensuring her story and struggles were highlighted.
In 2012, Figi's mother searched for CBD marijuana oil for her daughter's treatment. Figi began taking oil from the marijuana strain, "Hippie's Disappointment," which contained low THC, and was later renamed Charlotte's Web.
With the use of Charlotte's Web, Figi experienced an immediate reduction in her epileptic seizures, down from 300 a week to two or three per month.
While the use of medical marijuana was still illegal in many states, news of Figi's success spread and families with similar diagnoses started moving to Colorado Springs, where the drug was originally sold. Because of her story, she also gained worldwide notice and media attention.
In 2013, she was the subject of the CNN documentary Weed by Sanjay Gupta. She became a well-known figure in the U.S. and international medical marijuana movement and her story helped support U.S. legislation on medical marijuana. In 2019, Figi was the first child featured on a cover of High Times.
Net Worth and Salary
Although Charlotte Figi was a public figure, specific information about her net worth is not publicly available. Due to her young age and the circumstances surrounding her medical treatments, she did not have a career or salary in the traditional sense. However, her influence on the cannabis industry, particularly in advocating for pediatric medical cannabis, has led to an increase in awareness and potential advocacy-related earnings for her family.
Career, Business and Investments
Charlotte’s primary “career” was as a medical patient, but her story has significantly influenced the cannabis industry, leading to the creation of products specifically designed for children with epilepsy and other medical conditions. The strains of cannabis named in her honor, such as "Charlotte's Web," have been instrumental in changing perceptions of cannabis and encouraging further research. Charlotte’s story continues to inspire both medical professionals and advocates for cannabis legalization.
Social Network
Charlotte Figi's legacy is honored on various social media platforms, primarily through pages and groups dedicated to epilepsy awareness and medical cannabis advocacy. The “Charlotte's Web” strain has also maintained a strong presence on platforms like Instagram and Facebook, celebrating her memory and contributing to educational efforts about CBD and cannabis.
Education
Given her age, Charlotte was a student, but specific details about her education are not widely covered. Her experiences, however, highlighted the need for better educational resources concerning medical cannabis, particularly as it pertains to children's health and treatment options.
